Studies involving multiple aspects of plaque psoriasis evolution, persistence, and progression have produced clues and ...

Psoriasis involving the hands and feet affects only about 30% of patients with plaque psoriasis, but is a uniquely problematic form of the disease (Fretzin, Crowley, Jones, Young, & Sobell ...

Plaque psoriasis is the most common form ... Palmoplantar psoriasis affects the palms of hands and soles of feet, but is not ...

You’re also more likely to have this variation if you have GPP symptoms that affect your mouth and no personal history of plaque psoriasis. Some environmental factors, including certain ...

Clinical efficacy was evaluated using the Psoriasis Area and Severity Index (PASI), along with metabolic indicators such as ...

Examples include scalp, hands and feet, and genitals ... a recent study of apremilast in patients with mild/moderate plaque psoriasis that had not responded to one or more topical therapies.

Icotrokinra is efficacious and safe for treating moderate to severe plaque psoriasis among adolescents and adults when compared with placebo.

Icotrokinra achieved 75% complete skin clearance in adolescents with moderate to severe plaque psoriasis by week 24, indicating significant efficacy. The ICONIC-LEAD trial is the first to evaluate ...

Currently, there is no known cure for psoriasis, although a number ... with chronic moderate-to-severe plaque psoriasis involving the hands and feet. The 12-week study was the first randomized ...